Intuitive Surgical, Inc.  

(Public, NASDAQ:ISRG)   Watch this stock  
Find more results for ISRG
+9.73 (1.87%)
Feb 12 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 517.21 - 534.52
52 week 447.00 - 580.00
Open 523.15
Vol / Avg. 223,159.00/466,290.00
Mkt cap 19.75B
P/E 34.26
Div/yield     -
EPS 15.51
Shares 37.38M
Beta 0.66
Inst. own 91%
Apr 22, 2016
Intuitive Surgical Inc Annual Shareholders Meeting (Estimated) - 6:00PM EDT - Add to calendar
Apr 19, 2016
Q1 2016 Intuitive Surgical Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jan 21, 2016
Q4 2015 Intuitive Surgical Inc Earnings Call - Webcast
Jan 21, 2016
Q4 2015 Intuitive Surgical Inc Earnings Release
Jan 14, 2016
Intuitive Surgical Inc at JPMorgan Healthcare Conference
Nov 17, 2015
Intuitive Surgical Inc at Stifel Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin 28.09% 24.69%
Operating margin 36.35% 31.04%
EBITD margin - 34.79%
Return on average assets 15.89% 13.28%
Return on average equity 18.07% 15.30%
Employees 3,211 -
CDP Score - -


1020 Kifer Rd
SUNNYVALE, CA 94086-5301
United States - Map
+1-408-5232100 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Intuitive Surgical, Inc. designs, manufactures and markets da Vinci Surgical Systems and related instruments and accessories. The Company's da Vinci Surgical System consists of a surgeon's console, a patient-side cart and vision system. The da Vinci Surgical System provides its operating surgeons with control, range of motion, tissue manipulation and three-dimensional (3-D), high-definition (HD) vision. It allows surgeons to work through the small ports enabled by minimally invasive surgery (MIS) procedures. Its da Vinci Surgery utilizes computational, robotic and imaging technologies. The Company has four generations of da Vinci Surgical System: the da Vinci Xi Surgical System, the da Vinci Si Surgical System, the da Vinci S Surgical System and the standard da Vinci Surgical System. The Company focuses on five surgical specialties: urologic surgery, gynecologic surgery, general surgery, cardiothoracic surgery, and head and neck surgery.

Officers and directors

Lonnie M. Smith Chairman of the Board
Age: 70
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Gary S. Guthart Ph.D. President, Chief Executive Officer, Director
Age: 49
Bio & Compensation  - Reuters
Marshall L. Mohr Chief Financial Officer, Senior Vice President
Age: 59
Bio & Compensation  - Reuters
Salvatore J. Brogna Executive Vice President - Product Operations
Age: 60
Bio & Compensation  - Reuters
David J. Rosa Executive Vice President, Chief Commercial Officer
Age: 47
Bio & Compensation  - Reuters
Mark J. Meltzer Senior Vice President, General Counsel
Age: 65
Bio & Compensation  - Reuters
Myriam J. Curet Senior Vice President, Chief Medical Officer
Age: 58
Bio & Compensation  - Reuters
Colin Morales Senior Vice President - Manufacturing and Service Operations
Age: 51
Bio & Compensation  - Reuters
Jamie E. Samath Vice President, Corporate Controller, and Principal Accounting Officer
Age: 44
Bio & Compensation  - Reuters
Michael A. Friedman M.D. Director
Age: 70
Bio & Compensation  - Reuters